Screening compound: InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3

Screening compound: InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3
Screening compound: InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L856-0034

Molecular Formula

C21H16FN7O3S2 (C21 H16 FN7 O3 S2)

Compound Name

4-({3-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl}sulfonyl)-2,1,3-benzothiadiazole

IUPAC name

4-({3-[5-(4-fluorophenyl)-134-oxadiazol-2-yl]-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl}sulfonyl)-213-benzothiadiazole

SMILES

Cn(c(CC1)c2CN1S(c1cccc3nsnc13)(=O)=O)nc2-c1nnc(-c(cc2)ccc2F)o1

InChI

InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3

InChI Key

VIRCJKKAYDZKHW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27480697

InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3?
Check Price and Availability of InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C21H16FN7O3S2/c1-28-16-9-10-29(34(30,31)17-4-2-3-15-19(17)27-33-26-15)11-14(16)18(25-28)21-24-23-20(32-21)12-5-7-13(22)8-6-12/h2-8H,9-11H2,1H3 available by request